Gianni B. Scappaticci

Risk factors and impact of Clostridium difficile recurrence on haematology patients

D. Bixby, Gianni B. Scappaticci, Anthony J. Perissinotti, 2017, The Journal of antimicrobial chemotherapy.

Predictors for requiring re-induction chemotherapy in acute myeloid leukemia patients with residual disease on day 14 bone marrow assessment.

D. Bixby, Gianni B. Scappaticci, Anthony J. Perissinotti, 2017, Leukemia research.

Utility of methicillin‐resistant Staphylococcus aureus (MRSA) nasal screening in patients with acute myeloid leukemia (AML)

Patrick W. Burke, D. Bixby, Gianni B. Scappaticci, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Defibrotide Therapy for SARS-CoV-2 ARDS

R. Hyzy, T. Braun, P. Richardson, 2022, Chest.

Defibrotide Therapy for SARS-CoV-2 ARDS

R. Hyzy, T. Braun, P. Richardson, 2022, Chest.

The FOSSIL Study: FLAG or standard 7+3 induction therapy in secondary acute myeloid leukemia.

M. Talpaz, I. Maillard, D. Bixby, 2018, Leukemia research.

Impact of pharmacogenetics on intravenous tacrolimus exposure and conversions to oral therapy.

J. Rae, K. Kidwell, Gianni B. Scappaticci, 2021, Transplantation and cellular therapy.